Article
Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer.
Biomolecules - 8 Dec 2022
Liu Zihao, Gao Jingbo, Gu Ran, Shi Yu, Hu Hong, Liu Jianlan, Huang Jiefeng, Zhong Caineng, Zhou Wenbin, Yang Yaping, Gong Chang
Abstract excerpt
Anthracycline is a mainstay of treatment for breast cancer patients because of its antitumor activity. However, anthracycline resistance is a critical barrier in treating breast cancer. Thus, it is of great importance to uncover the molecular mechanisms underlying anthracycline resistance in breast cancer. Herein, we integrated transcriptome data, genetic alterations data, and clinical data of The Cancer Genome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
